Agios Pharmaceuticals Inc (AGIO)
44.82
-0.06
(-0.12%)
USD |
NASDAQ |
Nov 04, 16:00
44.82
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Gross Profit Margin (Quarterly): 91.27% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 91.27% |
| June 30, 2024 | 82.65% |
| March 31, 2024 | 92.34% |
| December 31, 2023 | 91.75% |
| September 30, 2023 | 91.44% |
| June 30, 2023 | 83.49% |
| March 31, 2023 | 90.12% |
| December 31, 2022 | 90.42% |
| September 30, 2022 | 85.30% |
| June 30, 2022 | 92.21% |
| March 31, 2022 | 59.25% |
| December 31, 2021 | |
| September 30, 2021 |
| Date | Value |
|---|---|
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 98.49% |
| June 30, 2019 | 98.84% |
| March 31, 2019 | 98.90% |
| December 31, 2018 | 97.66% |
| September 30, 2018 | 95.43% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
59.25%
Minimum
Mar 2022
92.34%
Maximum
Mar 2024
86.39%
Average
90.42%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| Regeneron Pharmaceuticals Inc | 86.80% |
| Ligand Pharmaceuticals Inc | 93.00% |
| ADMA Biologics Inc | 53.60% |
| AnaptysBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 71.30% |
| Return on Assets | 62.91% |
| Return on Invested Capital | 71.30% |
| Operating Margin (Quarterly) | -1.15K% |
| Return on Net Operating Assets | 744.8% |